Versantis is a clinical-stage pharmaceutical company developing a new generation of orphan medicines to revolutionize the care of patients with liver and rare pediatric diseases. We address the unmet medical needs in emergency care. Our mission is to support acute decompensations of cirrhosis and to save infants born with rare genetic disorders.
Location: Switzerland, Zurich
Member count: 11-50
Founded date: 2015
Investors 1
| Date | Name | Website |
| - | Esperante | esperante.... |
Mentions in press and media 1
| Date | Title | Description | Category | Author | Source |
| 19.09.2022 | GENFIT acq... | The acquisition of Versantis... | Financing | - | startuptic... |